Imaging of atherosclerosis (Part II)

Wiener Klinische Wochenschrift

Volumn 108, Issue 5, 1996, Pages 123-132

  Kritz, H ^a,b   Underwood, S R ^c   Sinzinger, H ^a,d,e  

^a Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^b Rehab Center Engelsbad Melanie   (Austria)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF VIENNA   (Austria)

^e Inst Diagn Treatm Lipid D   (Austria)

Author keywords

atherosclerosis; in vivo imaging; planar scintigraphy; positron emission tomography; single photon emission tomography

Indexed keywords

8 QUINOLINOL INDIUM IN 111; APOLIPOPROTEIN B; CHOLESTEROL ESTER; FIBRINOGEN; FIBRINOGEN I 125; FIBRONECTIN; IMMUNOGLOBULIN G; INDIUM 111; IODINE 123; IODINE 125; IODINE 131; LOW DENSITY LIPOPROTEIN; PORPHYRIN; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; HUMAN; IMAGING; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; AORTA; ARTERIES; ARTERIOSCLEROSIS; HUMANS; PREDICTIVE VALUE OF TESTS; RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029930441     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Anitschkov NN (1933) Experimental arteriosclerosis in animals. In: Cowdry EC (ed) Arteriosclerosis: survey of the problem. MacMillan. New York, pp 271-322
2. Virchow R (1856) Phlogose und Thrombose im Gefäßsystem. Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Hirsch, Berlin
3. Rokitansky G (1852) Über einige der wichtigsten Krankheiten der Arterien. KMK Hof und Staatsdruckerei, Wien
4. 125I-labelled fibrinogen into coronary arterial thrombi in acute myocardial infarction in man. Lancet i: 387-390
5. 131I-fibrinogen in a coronary artery thrombus detected in vivo with a scintillation camera. Cardiovasc Res 8: 715-720
6. 123I-fibrinogen. Lancet i: 242-244
7. Thakur ML, Welch MJ, Joist JH, Coleman RE (1976) Indium-111 labelled platelet studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res 9: 345-357
8. 111In-labelled autologous platelets. J Nucl Med 21: 548-549
9. 123I-low density lipoproteins (LDL) in the diagnosis of human atherosclerotic lesions. Circulation 72: 163
10. 111Indium. Arch Psychiatr Nervenkr 231: 449-452
11. 111In-markierten Thrombozyten: Therapiekontrolle bei Acetylsalicylsäure (ASS)-behandelten Schlaganfallpatienten. Nucl Compact 16: 30-31
12. 111In-oxine. J Neurol 229: 255
13. Sinzinger H, Fitscha P (1984) Epoprostenol and platelet deposition in atherosclerosis. Lancet i: 905-906
14. Lees RS, Lees AM, Strauss HW (1983) External imaging of human atherosclerosis. J Nucl Med 24: 154-156
15. 99mTc-labelled lipoprotein metabolism and non-invasive imaging of atherosclerotic lesions. Eur J Nucl Med 4: 198
16. Roberts AB, Strauss HW, Lees RS, Taveras J, Kopiwoda S (1980) Low density lipoproteins concentrate in damaged arterial wall. Circulation 62 [Suppl] III: 97-103
17. 99mTc-labelled low density lipoproteins. Arteriosclerosis 8: 461-470
18. Lees RS, Garabedian JD, Lees AM, Schumacher DJ, Miller A, Isaacsohn JL, Derksen A, Strauss HW (1985) Technetium-99m-low density lipoproteins: preparation and bio-distribution. J Nucl Med 26: 1056-1062
19. Virgolini I, Angelberger P, O'Grady J, Sinzinger H (1991) Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 18: 944-947
20. Sinzinger H, Angelberger P (1988) Imaging and kinetic studies with radiolabelled autologous low-density lipoproteins (LDL) in human atherosclerosis. Nucl Med Commun 9: 859-866
21. Virgolini I, Angelberger P, Lupattelli G, Pidlich J, Sinzinger H (1989) In-vivo-Einstrom autologer radioaktiv markierter low-density Lipoproteine (LDL) in menschliche Gefäße. Wien Klin Wochenschr 23: 798-805
22. Virgolini I, Rauscha F, Lupattelli G, Angelberger P, Ventura A, O'Grady J, Sinzinger H (1991) Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 18: 984-951
23. 123I-low density lipoprotein. Eur J Nucl Med 12: 291-292
24. 123I-labelled autologous low-density lipoproteins (LDL). In: Crepaldi G, Gotto AM, Manuato E, Baggio G (eds) Atherosclerosis VIII. Excerpta Medica, Amsterdam, pp 655-658
25. Bevilaqua MP, Pober JS, Wheeler H (1985) Interleukin-1 acts on human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 76: 2003-2007
26. Harlan JM (1985) Leukocyte-endothelial interactions. Blood 65: 513-519
27. Wallis WJ, Harlan M (1986) Effector functions of endothelium in inflammatory and immunologic reactions. Pathol Immunopathol Res 5: 73-77
28. Gerrity RG, Goss JA, Soby LM (1985) Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis 5: 55-66
29. Kim JA, Berliner JA, Territo M, Fogelman AM (1990) Inducation of a monocyte binding molecule on rabbit aortic endothelial cells by minimally oxidized LDL. Faseb J 4: 341
30. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ (1990) Induction of endothelial cell expression of granulocyte- and macrophage-colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254-256
31. Gerrity RG (1989) Morphological development of the atherosclerotic plaque. In: Subbiah MTR (ed) Atherosclerosis: a pediatric perspective. CRC Press, Boca Raton, pp 9-30
32. Daoud AJ, Jarmolych J, Augustyn JM, Frith KE (1981) Sequential morphologic studies of regression of advanced atherosclerosis. Arch Pathol Lab Med 105: 233-239
33. 111In-oxine labelled human peripheral blood mononuclear cells in patients with lymphatic malignancies. J Nucl Med 3: 1005-1011
34. 111In-oxine for reinjection in patients with atherosclerosis. Prog Clin Biol Res 355: 271-280
35. 111In-oxine monocyte scintigraphy in atherosclerosis. Eur J Nucl Med 16: 503
36. 111In of a viable population of blood monocytes. Prog Clin Biol Res 355: 261-270
37. 111Indium-oxine for reinjection in patients with atherosclerosis. Nucl Med Res 3: 51
38. 111In-labelled monocytes in atherosclerosis. Circulation 82 [Suppl ] III: 517
39. 111Indium tropolone, a new high affinity platelet label: preparation and evaluation of labelling parameters. J Nucl Med 22: 981-987
40. 131I-cholesterol uptake on aortocoronary femoral vein bypass grafts in dogs. Thromb Haemost 46: 74
41. 3H-cholesteryl linolyl ether for the quantification of plasma cholesteryl ester influx into the aortic wall in hypercholesterolemic rabbits. Arteriosclerosis 2: 282-289
42. DeGalan MR, Schwendner SW, Weichert JP (1981) Radio-iodinated cholesteryl iopanoate as a probe for the in vivo visualization of atherosclerotic lesions in animals. Arteriosclerosis 2: 281-289
43. 125Iodine cholesteryl iopanoate for measuring extent of atherosclerosis in rabbits. J Nucl Med 29: 503-508
44. Spears JR, Shopshire D, Paulin S (1983) Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative. J Clin Invest 71: 395-399
45. Kessel D, Sykes E (1984) Porphyrin accumulation by atheromatous plaques of the aorta. Photochem Photobiol 40: 59-61
46. Litvack F, Grundfest WS, Forrester JS (1985) Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits. Am J Cardiol 56: 667-671
47. Palac RT, Turner FE, Gray LL (1987) Detection of experimental atherosclerosis with radiolabelled hematoporphyrin derivative. Circulation 76: 203
48. 111In. Int J Appl Radiat Isot 35: 691-692
49. 111Indium radiolabelled hematoporphyrin derivative. Nucl Med Commun 10: 841-850
50. Fischman AJ, Rubin RH, Khaw BA, Kramer PB, Wilkinson R, Ahmad M, Needelman M, Locke E, Nossiff ND, Strauss HW (1989) Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin. J Nucl Med 30: 1095-1100
51. 111Indium-polyclonal immunoglobulin G to quantitative atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. J Nucl Med 34: 1316-1321
52. Kritz H, Schmid P, Karanikas G, Rodrigues M, Sinzinger H (1995) Detection of early atherosclerotic lesions in the carotid artery-experimental and preliminary human data. Intern J Angiology (in press)
53. 131Iodine-labelled fibronectin: potential agent for imaging atherosclerotic lesion and thrombus. J Nucl Med 29: 1264-1267
54. Collins EF, Carew TE (1990) Focal elevation of concentration of fibronectin but not albumin in atherosclerotic lesion susceptible sites in rabbit. Faseb J 4: 343
55. Shih IL, Lees RS, Chang MY, Lees AM (1990) Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall. Proc Natl Acad Sci 87: 1436-1440
56. Borer JS (1993) Atherosclerosis imaging: pathophysiological assessment for a new era. J Nucl Med 34: 1321-1325
57. Hardoff R, Braegelmann F, Zanzonico P, Herrold EM, Lees RS, Lees R, Dean R, Lister-James J, Borer JS (1992) Accumulation of Tc-99m in atherosclerotic lesions in aorta and carotid arteries in Watanabe heritable hyperlipidemic rabbits. Clin Res 3: 667
58. Hardoff R, Braegelmann F, Zanzonico P, Herrold EM, Lees RS, Lees R, Dean R, Lister-James J, Borer JS (1992) Imaging atherosclerosis with 1-123 SP4. J Nucl Med 33: 845
59. Hardoff R, Braegelmann F, Zanzonico P, Herrold EM, Lees RS, Lees R, Dean R, Lister-James J, Borer JS (1992) Autoradiographic identification of atherosclerosis with I-125 SP4. Circulation 86 [Suppl] I: 708
60. Vallabhajosula S, Goldsmith SJ, Buttram S, Lister-James J, Dean RT (1992) Non-invasive imaging of atherosclerotic lesions in rabbits with Tc-99m labelled peptides. Circulation 86 [Suppl] I: 709
61. Porenta G (1994) Positron emission tomography: physics, instrumentation, and image analysis. Wien Klin Wochenschr 106: 466-477
62. Blomqvist G (1991) Kinetic analysis. Wien Klin Wochenschr 103: 451-457
63. Schelbert H, Czernin J (1994) Cardiologie applications of positron emission tomography. Wien Klin Wochenschr 106: 487-495
64. Schelbert H, Sinzinger H, Sochor H (1994) Positron emission tomography - what? how? what for? Wien Klin Wochenschr 106: 465
65. Kuhl DE, Wagner HN, Alavi A, Coleman RE, Gould KL, Larson StM, Mintun MA, Siegel BA, Strudier PK (1988) Positron emission tomography: clinical status in the United States in 1987. ACNP/SNM Task Force on Clinical PET. J Nucl Med 29: 1136-1143
66. Jones RH, McEwan P, Newman GE (1981) Accuracy of diagnosis of coronary artery disease by measurement of left ventricular function during rest and exercise. Circulation 64: 586-601
67. Tillisch J, Brunken R, Marschall R, Schwaiger M, Mandelkern M, Phelps ME, Schelbert HR (1986) Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 314: 884-888
68. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR (1987) Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 10: 557-567
69. Brunken R, Tillisch J, Schwaiser M, Child JS, Marshall R, Mandelkern M, Phelps ME, Schelbert HR (1986) Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence of persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 73: 951-963
70. Schwaiger M (1994) Myocardial perfusion imaaing with PET. J Nucl Med 35; 693-698
71. Hoffman E, Phelps M (1986) Positron emission tomography: principles and quantitation. In: Phelps M (ed) Positron emission tomography and autoradiography: principles and applications for the brain and heart. Raven Press, New York, pp 237-286
72. Schwaiger M, Hicks R (1991) The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 32: 565-578
73. 68Gallium lipophilic complexes for labelling platelets. J Nucl Med 26: 1429-1437
74. Moerlein SM, Daugherty A, Sobel BE, Welch MJ (1991) Metabolic imaging with gallium-68- and indium-111-labelled low-density lipoprotein. J Nucl Med 32: 300-307
75. Patterson RE, Horowitz StF, Eisner RL (1994) Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 4: 286-310
76. Strauss HW (1991) Clinical PET: its time has come. J Nucl Med 32: 561-584
77. 111Indium-labelled platelets in patients with aortic aneurysms. Arch Surg 117: 1170-1174
78. 111In-labelled platelets. In: Raynaud C (ed) Nuclear medicine and biology. Pergamon, Paris, pp 65-68
79. 111In-labelled platelets: a comparison with scanning-electron micrographs. Radiology 145: 155-162
80. 111Indium platelet scintigraphy in cerebrovascutar disease. Neurology 32: 938-943
81. 111In-labelled platelets response to carotid endarterectomy. Artery 93: 424
82. 111Indium-labelled platelets and angiography. Invest Radiol 26: 655-659
83. 99mTc monoclonal antifibrin antibody. Circulation 85: 298-304
84. 135I-labelled serum lipoproteins in rat aorta. Z Zellforsch 138: 223-237
85. 131I-LDL in aortocoronary femoral vein bypass graft in dogs. Arteriosclerosis 2: 404
86. 99mTc-LDL. J Nucl Med 28: 610
87. 125I-endothelin-1 accumulation in experimental arterial wall injury. Eur J Nucl Med 20: 1141-1145
88. 99mTc-LDL(s) labelled by two different methods for scintigraphic detection of experimental atherosclerosis in rabbits. Arterioscler Thromb 13: 78-83
89. Kurata C, Wilkinson RA, Molea N, Narula J, Callahan RJ, Fischman AJ, Strauss HW (1992) Localization of radioiodinated endothelin-1 in injured aortic tissue of cholesterol fed rabbits. J Nucl Med 33: 845P
90. 111Indium polyclonal human immunoglobulin G in human and experimental atherosclerosis. In: Bergmann H, Sinzinger H (eds) Radioactive isotopes in clinical medicine and research. Birkhäuser, Basel, pp 329-334
91. Khaw BA, Narula J, Ditlow C, Chen F, O'Donnell SM, Calenoff E, Nossiff ND, Strauss HW (1992) A new approach to imaging experimental atherosclerotic lesions with monoclonal antibody Z2D3: enhanced targeting utilizing antibody-avidin-biotin interactions. J Nucl Med 33: 934
92. 111In-labelled platelets: a combined clinical and theoretical study. In: Raynaud C (ed) Nuclear medicine and biology. Pergamon, Paris, pp 887-890
93. 111Indium-labelled autologous platelet scintigraphy for the detection of vascular thrombi in ischemic cerebrovascular disease. In: Raynaud C (ed) Nuclear medicine and biology, Pergamon, Paris, pp 1759-1761
94. 99mtechnetium human serum albumin. J Nucl Med 25: 556-563
95. 111Indium-labelled LDL: a potential agent for imaging atheroscierotic disease and lipoprotein biodistribution. J Nucl Med 31: 343-350
96. Lupattelli G, Palumbo R, Deleide G, Ventura S (1989) Radiolabelled LDL in the in vivo detection of human atherosclerotic plaques. In: Crepaldi E, Gotto AM, Manzato E, Baggio G (eds) Atherosclerosis VIII. Excerpta Medica, Amsterdam, pp 645-653
97. 99mTc-LDL. In: Glagov S, Newman WP, Schaffer SA (eds) Pathobiology of the human atherosclerotic plaque. Springer. Berlin Heidelberg New York Tokyo, pp 841-852
98. Vallabhajosula S, Ali KSM, Goldsmith SJ (1993) Evaluation of technetium-99m-labelled peptides for imaging atherosclerotic lesions in vivo. J Nucl Med 34: 66